40. 高安動脈炎 Takayasu arteritis Clinical trials / Disease details

臨床試験数 : 24 / 薬物数 : 40 - (DrugBank : 18) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 110

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04299971 (ClinicalTrials.gov)	March 1, 2020	5/3/2020	Efficiency of Methotrexate and Tofacitinib in Mild and Moderate Patients	Randomized Open-label Study in Mild and Moderate Patients With Takayasu Arteritis Between Methotrexate and Tofacitinib Based on the ECTA Cohort.	Takayasu Arteritis;Methotrexate;Inhibition;Treatment	Drug: Methotrexate Tablets;Drug: Tofacitinib tablet	Shanghai Zhongshan Hospital	NULL	Recruiting	14 Years	100 Years	All	130	Phase 4	China
2	NCT03096275 (ClinicalTrials.gov)	March 16, 2017	13/3/2017	Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis	Comparison of the Efficacy of Mycophenolate Mofetil Combined With Methotrexate and Cyclophosphamide for the Treatment of Takayasu's Arteritis	Takayasu Arteritis	Drug: MMF;Drug: CYC;Drug: Glucocorticoids;Drug: MTX;Drug: AZA	Chinese SLE Treatment And Research Group	Peking Union Medical College Hospital	Active, not recruiting	18 Years	N/A	All	138	Phase 3	China